RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2018

Jun 8, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2018-06-06

Reporting Person: Mathers Edward T (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-06	Stock Option (right to buy)	$34.89	A	10000	Acquired	2028-06-05	Common Stock (10000)	Direct

Footnotes

F1: The options fully vest upon the earlier of (i) 1 year from the date of grant or (ii) the date of the Issuer's next annual meeting of the stockholders.